New Hampshire Caught Anthem With Hundreds of Insurance Violations — Here’s What That Means for Patients Who Used Their Coverage Between 2022 and 2023

New Hampshire Insurance Department fined Anthem Health Plans of New Hampshire Inc. and Matthew Thornton Health Plan $520,000 for “hundreds of violations” found in a market conduct exam covering Jan 1, 2022 to Nov 30, 2023. The issues involved provider credentialing, provider directory accuracy, and mental health parity. $300,000 is due within 30 days; $220,000 is suspended for two years if compliance is maintained.

Original reporting
Published Aug 13, 2026, 2:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 2:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
New Hampshire Caught Anthem With Hundreds of Insurance Violations — Here’s What That Means for Patients Who Used Their Coverage Between 2022 and 2023 — source image
Decision brief

The 30-second read

$ELVBearishLow
01

Why it matters

The order documents failures in provider credentialing monitoring (including third-party credentialers), provider directory accuracy, and mental health parity compliance. It creates a documented basis for affected members to request claim reviews for that period and sets a compliance incentive via a suspended fine contingent on corrective-plan execution through late 2027.

02

Market read

This is a concrete state enforcement action against Elevance’s Anthem unit, with a defined payment schedule and compliance milestones, but the fine size suggests limited immediate financial impact.

03

What to watch

The article does not quantify claim leakage, reserve changes, or patient restitution amounts; the main tradable signal is the compliance trajectory and whether additional state actions follow, not the fine magnitude alone.

Relevance 6/10Novelty 5/10Timing: Final order dated Nov 24, 2025, with $300,000 due within 30 days of the order and $220,000 suspended contingent on compliance through late 2027.

Background

The New Hampshire Insurance Department issued a Final Order after a targeted market conduct examination of Anthem Health Plans of New Hampshire and its subsidiary Matthew Thornton Health Plan for Jan 1, 2022 to Nov 30, 2023.

Company-level read

Ticker impact

$ELVBearishMedium confidence
Context

New Hampshire Insurance Department fined Anthem Health Plans of New Hampshire $520,000 for provider credentialing, directory accuracy, and mental health parity violations (2022-2023).

Expected impact

Near-term: limited direct earnings impact given the fine size, but could pressure sentiment and increase perceived regulatory/compliance risk. Medium-term: watch for any follow-on state actions or compliance verification updates.

Evidence & confidence

The article discloses a specific final order, fine payment schedule ($300k due within 30 days, $220k suspended for two years), and compliance plan expectations through late 2027. However, it does not provide new financial guidance or quantify broader reserve/claims impacts.

Market effects

Adds to ongoing state scrutiny of managed-care compliance (credentialing, provider directories, and mental health parity), potentially increasing compliance costs and litigation/regulatory tail risk across peers.

New Hampshire enforcement may prompt other states to intensify market conduct examinations and directory/credentialing oversight for similar plans.

Primarily US regulatory risk; limited direct global relevance unless it signals broader US managed-care enforcement escalation.

Counterpoint

The $520,000 fine is small relative to Elevance Health’s scale, and the suspended portion is contingent on corrective actions, suggesting manageable financial impact if remediation is executed.

Key entities

  • Anthem Health Plans of New Hampshire Inc.

    Subject of the New Hampshire Final Order and fined for credentialing, directory accuracy, and mental health parity violations.

  • Matthew Thornton Health Plan

    Named subsidiary in the Final Order alongside Anthem Health Plans of New Hampshire.

  • New Hampshire Insurance Department

    Issued the Final Order and identified hundreds of violations across three compliance areas.

  • D.J. Bettencourt

    Commissioner quoted regarding Anthem’s monitoring and compliance failures.

  • Keith Nyhan

    Deputy Commissioner quoted framing the outcome as constructive engagement and collaboration on a corrective plan.

Related articles

$ELVMed

Elevance accuses Hamaspik of poaching staff to copy its plans

Elevance Health filed a complaint on July 27, 2026, in the US District Court for the Southern District of New York against managed care organization Hamaspik, Inc. and four of its own former employees. According to the filing, Hamaspik has run a "coordinated scheme" since December 2025 to hire the people who run Elevance's New York Managed Long-Term Care (MLTC) and Fully Integrated Dual Eligible Special Needs (FIDE) plans, which combine Medicare and Medicaid coverage in a single product.

$ELVMed

Elevance Health (ELV) Lifted Full Year Guidance, Is The 11% Undervaluation Still There?

Simply Wall St reports Elevance Health (ELV) paired Q2 results with higher full-year 2026 diluted EPS guidance of at least $20.10, despite lower quarterly net income. It cites ELV’s 90-day return of 12.36% and 1-year total shareholder return of 33.94%. A valuation narrative pegs fair value at $436.52 versus $389.09 prior close, implying undervaluation, contingent on Medicaid margins and medical cost trends.

$ELVMed

What's A Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets?

Elevance Health (ELV) reported adjusted EPS of $7.45 versus $6.27 consensus and raised 2026 adjusted diluted EPS guidance to at least $27, with Medicare Advantage targeting at least a 2% operating margin. Shares fell 8.5% as Medicaid operating margin guidance stayed at -1.75%. Elevance said it will exit D.C. Medicaid and expects further Medicaid market exits in 12-18 months.

$ELVMedAI 8/10

Elevance Health Q2 Earnings Call Highlights

Elevance Health (NYSE:ELV) management said 2026 is expected to be the trough year for Medicaid margins, with improvement later supported by better rate alignment and care management actions. The company expects to exit additional low-sustainable Medicaid markets over 12 to 18 months. It reported Q2 operating cash flow of $1.9B and raised full-year outlook to at least $6B.

$ELVMed

Health insurance stocks slide after Elevance highlights margin pressures (ELV)

Elevance Health (ELV) shares fell in premarket after its Q2 results showed margin pressure in the Health Benefits segment. Adjusted operating margin fell to 3.6% from 5.0% a year earlier. Despite revenue of $50.47B and adjusted EPS of $7.45, investors cited weaker underlying profitability. Peers including UNH, MOH, HUM, CNC and CVS also dropped ahead of UNH earnings.